Lead investor Manmohan Patel projects the combined entity could reach $100 million in annual revenue if the transaction reaches completion. This potential acquisition aligns with a broader strategy at Tevogen, which is currently scouting additional deals within the life sciences and healthcare sectors to scale its market presence.
Tevogen Eyes HRK Healthcare Acquisition to Boost Revenue
Tevogen has signed a non-binding letter of intent to evaluate a takeover of HRK Healthcare, a move the company anticipates will broaden its infrastructure capabilities. By integrating HRK’s operations, Tevogen aims to establish a dedicated healthcare services arm equipped with specialized management functions.
Comments (0)
No comments yet. Be the first!